These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6463886)

  • 21. [A rare form acroosteolysis].
    FOGEL M; VAJDA D; URAI L
    Fortschr Geb Rontgenstr Nuklearmed; 1959 Aug; 91():243-8. PubMed ID: 13849819
    [No Abstract]   [Full Text] [Related]  

  • 22. Plethysmographic patterns in scleroderma after percutaneous G.A.G. treatment.
    Costantini A; Muzzio A; Agus GB
    Boll Chim Farm; 1986 Oct; 125(10):111S-115S. PubMed ID: 3566923
    [No Abstract]   [Full Text] [Related]  

  • 23. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment.
    Lee P; Leung FY; Alderdice C; Armstrong SK
    J Rheumatol; 1983 Dec; 10(6):930-8. PubMed ID: 6663597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemodynamic response of the digital artery to heat and cold in normal subjects, in systemic scleroderma and in Raynaud's disease].
    Vayssairat M; Mathieu JF; Housset E
    J Mal Vasc; 1984; 9(1):7-10. PubMed ID: 6707534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The handheld dermatoscope as a nail-fold capillaroscopic instrument.
    Bergman R; Sharony L; Schapira D; Nahir MA; Balbir-Gurman A
    Arch Dermatol; 2003 Aug; 139(8):1027-30. PubMed ID: 12925391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon.
    Maricq HR; Weinberger AB; LeRoy EC
    J Rheumatol; 1982; 9(2):289-91. PubMed ID: 7097688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of systemic scleroderma].
    Guĭda PP
    Klin Med (Mosk); 1983 Jun; 61(6):82-5. PubMed ID: 6887774
    [No Abstract]   [Full Text] [Related]  

  • 28. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
    Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
    J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinico-immunological characteristics of the course of systemic scleroderma].
    Musaev SK; Speranskiĭ AI
    Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycosaminoglycans in scleroderma and scleredema.
    Fleischmajer R; Perlish JS
    J Invest Dermatol; 1972 Mar; 58(3):129-32. PubMed ID: 4259052
    [No Abstract]   [Full Text] [Related]  

  • 31. Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon.
    Rodnan GP; Myerowitz RL; Justh GO
    Medicine (Baltimore); 1980 Nov; 59(6):393-408. PubMed ID: 7442530
    [No Abstract]   [Full Text] [Related]  

  • 32. Ischemic complications of radial artery cannulation: an association with a calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia variant of scleroderma.
    Rose SH
    Anesthesiology; 1993 Mar; 78(3):587-9. PubMed ID: 8457059
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxidative stress, microvascular dysfunction, and scleroderma: an association with potential therapeutic implications, a commentary on "Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis".
    Chung CP; Avalos I; Stein CM
    Free Radic Biol Med; 2006 May; 40(10):1698-9. PubMed ID: 16678008
    [No Abstract]   [Full Text] [Related]  

  • 34. [Capillaroscopy].
    Marquet Palomer R; Vilardell Tarrés M
    Med Clin (Barc); 1986 Mar; 86(9):380-2. PubMed ID: 3702532
    [No Abstract]   [Full Text] [Related]  

  • 35. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Telangiectasic form of acrosclerosis].
    Merklen FP; Jaquillat C; Buzacoux J
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):415. PubMed ID: 5585187
    [No Abstract]   [Full Text] [Related]  

  • 38. [Progressive systemic sclerosis. Clinical and laboratory study].
    Aranguena Necochea LR; Sánchez Hurtado L; Hinojosa Linares W; Arroyo L
    Rev Clin Esp; 1982 Aug 15-31; 166(3-4):149-52. PubMed ID: 7146536
    [No Abstract]   [Full Text] [Related]  

  • 39. [Scleroderma microangiopathy. Physiopathogenic hypothesis].
    Fiessinger JN; Cailleri JP; Mignot J; Kazandjian S; Vayssairat M; Housset E
    Rev Med Interne; 1980; 1(1):61-4. PubMed ID: 7232908
    [No Abstract]   [Full Text] [Related]  

  • 40. Difficulty in detecting reperfusion injury increment in oxidative stress among patients with primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Rieley F; Braganza JM; Jayson MI
    J Rheumatol; 1995 Feb; 22(2):374-5. PubMed ID: 7738971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.